Skip to content
Home/Companies/Biotech/T-Curx

T-Curx

Biotech·Germany·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns T-Curx?

T-Curx is currently owned by Bayern Kapital through Seedfonds Bayern (1996 vintage), since 2025.

Hand-verified · updated 2026-08-10

Bayern Kapital
Investor
Bayern Kapital
Seedfonds Bayern · 1996 · VC

Key facts

HQGermany
SectorBiotech
StatusActive

More from Seedfonds Bayern

Other portfolio companies in the same fund.

Constellr
Constellr
Active
Aerospace & DefenceGermany· 2026
encosa
encosa
Active
EnergyGermany· 2026
Ewigbyte
Ewigbyte
Active
Deep TechGermany· 2026
Exergy3
Active
ClimateTechUnited Kingdom· 2026
NanoStruct
NanoStruct
Active
Deep TechGermany· 2026
Nature Robots
Active
AgTechGermany· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track T-Curx

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on T-Curx.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue